跳至主要内容
临床试验/JPRN-UMIN000020537
JPRN-UMIN000020537招募中未知

Therapeutic efficacy and safety of telmisartan in patients with non-alcoholic fatty liver disease (NAFLD) and hypertension: exploratory research - Efficacy and safety of telmisartan in patients with NAFLD and hypertension

Department of General Internal Medicine, Kyushu University Hospital0 个研究点目标入组 50 人开始时间: 2016年1月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Treatment histody of ARB, ACE inhibitor, renin inhibitor, or thiazolidine (2) History of hepatic disease, such as chronic hepatitis C or concurrent active hepatitis B (serum positive for hepatitis B surface antigen), autoimmune hepatitis, or primary biliary cirrhosis (PBC) (3) Secondary hypertension (4) History of allergy for telmisartan (5) Pregnancy or lactation in women (6) Inadequacy for this therapy

研究者

发起方
Department of General Internal Medicine, Kyushu University Hospital

相似试验